It is crucial to pursue workup for patients with isolated thrombocytosis through testing for the presence of the BCR-ABL fusion gene or the Philadephia chromosome in both PB and the BM in order to distinguish CML from essential thrombocythemia. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.